We found that neither NF-κB nor IFN signatures were present in patients with one functional copy of VHL. By contrast, ccRCC samples harboring biallelic loss of VHL (whether familial or sporadic in origin) displayed robust expression of both NF-κB and IFN signatures (Figure 5). This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.